244 related articles for article (PubMed ID: 17577106)
1. The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
Brigadeau F; Gelé P; Wibaux M; Marquié C; Martin-Nizard F; Torpier G; Fruchart JC; Staels B; Duriez P; Lacroix D
J Cardiovasc Pharmacol; 2007 Jun; 49(6):408-15. PubMed ID: 17577106
[TBL] [Abstract][Full Text] [Related]
2. Chronic activation of peroxisome proliferator-activated receptor-alpha with fenofibrate prevents alterations in cardiac metabolic phenotype without changing the onset of decompensation in pacing-induced heart failure.
Labinskyy V; Bellomo M; Chandler MP; Young ME; Lionetti V; Qanud K; Bigazzi F; Sampietro T; Stanley WC; Recchia FA
J Pharmacol Exp Ther; 2007 Apr; 321(1):165-71. PubMed ID: 17215446
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
Vikramadithyan RK; Hirata K; Yagyu H; Hu Y; Augustus A; Homma S; Goldberg IJ
J Pharmacol Exp Ther; 2005 May; 313(2):586-93. PubMed ID: 15671204
[TBL] [Abstract][Full Text] [Related]
5. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
[TBL] [Abstract][Full Text] [Related]
6. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effect of combination of fenofibrate and rosiglitazone in pressure overload-induced cardiac hypertrophy in rats.
Rose M; Balakumar P; Singh M
Pharmacology; 2007; 80(2-3):177-84. PubMed ID: 17570955
[TBL] [Abstract][Full Text] [Related]
10. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
Engle SK; Solter PF; Credille KM; Bull CM; Adams S; Berna MJ; Schultze AE; Rothstein EC; Cockman MD; Pritt ML; Liu H; Lu Y; Chiang AY; Watson DE
Toxicol Sci; 2010 Apr; 114(2):183-92. PubMed ID: 20044590
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
[TBL] [Abstract][Full Text] [Related]
13. Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.
Lionetti V; Linke A; Chandler MP; Young ME; Penn MS; Gupte S; d'Agostino C; Hintze TH; Stanley WC; Recchia FA
Cardiovasc Res; 2005 Jun; 66(3):454-61. PubMed ID: 15914110
[TBL] [Abstract][Full Text] [Related]
14. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
15. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
16. Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia.
Nerheim P; Birger-Botkin S; Piracha L; Olshansky B
Circulation; 2004 Jul; 110(3):247-52. PubMed ID: 15226218
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
18. Development of porcine model of chronic tachycardia-induced cardiomyopathy.
Paslawska U; Gajek J; Kiczak L; Noszczyk-Nowak A; Skrzypczak P; Bania J; Tomaszek A; Zacharski M; Sambor I; Dziegiel P; Zysko D; Banasiak W; Jankowska EA; Ponikowski P
Int J Cardiol; 2011 Nov; 153(1):36-41. PubMed ID: 20880599
[TBL] [Abstract][Full Text] [Related]
19. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
[TBL] [Abstract][Full Text] [Related]
20. Suppression of allergen-induced airway inflammation and immune response by the peroxisome proliferator-activated receptor-alpha agonist fenofibrate.
Delayre-Orthez C; Becker J; Auwerx J; Frossard N; Pons F
Eur J Pharmacol; 2008 Feb; 581(1-2):177-84. PubMed ID: 18096152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
